Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions

scientific article published on 10 October 2016

Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.01872-16
P932PMC publication ID5119027
P698PubMed publication ID27736755

P2093author name stringDaniel C Nelson
Hongping Wei
Hang Yang
Yunpeng Li
Yuhong Li
Mengyue Wang
Sara B Linden
Xiaoran Shang
Yongli Bi
P2860cites workEffects of glucose and fluoride on competition and metabolism within in vitro dental bacterial communities and biofilmsQ44010769
Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzymeQ44607884
Inhibitory effect of some herbal extracts on adherence of Streptococcus mutansQ44892291
Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitisQ46602101
Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens.Q53802821
Lytic bacteriophages ofStreptococcus mutansQ87060424
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzymeQ24609957
A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening methodQ27304933
Analysis of the effects of chlorhexidine on oral biofilm vitality and structure based on viability profiling and an indicator of membrane integrity.Q33202197
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureusQ33525230
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzymeQ33555987
Physico-chemistry of initial microbial adhesive interactions--its mechanisms and methods for studyQ33611476
Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of developmentQ33874627
Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogensQ34114172
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in ratsQ34123647
Engineered bacteriophage lysins as novel anti-infectivesQ34349552
Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin.Q34655703
A review of the efficacy of chlorhexidine on dental caries and the caries infectionQ35106534
Competence-dependent endogenous DNA rearrangement and uptake of extracellular DNA give a natural variant of Streptococcus mutans without biofilm formationQ35274076
Solving the etiology of dental cariesQ35461809
Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suisQ35599168
Isolation of a Novel Phage with Activity against Streptococcus mutans Biofilms.Q35785449
Biology and genome sequence of Streptococcus mutans phage M102AD.Q35827175
Using a Novel Lysin To Help Control Clostridium difficile InfectionsQ36290571
The role of sucrose in cariogenic dental biofilm formation--new insightQ36602378
Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureusQ37026612
Role of Streptococcus mutans in human dental decayQ37062855
Biology, immunology, and cariogenicity of Streptococcus mutansQ37065366
Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infectionQ37070575
In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolasesQ38282910
Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.Q38325227
Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans.Q39639225
Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strainsQ39730777
Quantification and Correlation of Oral Candida with Caries Index Among Different Age Groups of School Children: A Case-Control StudyQ39744653
TiF4 and NaF varnishes as anti-erosive agents on enamel and dentin erosion progression in vitro.Q41247026
Oral streptococci... products of their environmentQ41718989
PERIODONTAL LESIONS IN THE SYRIAN HAMSTER. III. FINDINGS RELATED TO AN INFECTIOUS AND TRANSMISSIBLE COMPONENT.Q43470994
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.Q43511826
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolaseQ43820230
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectStreptococcus mutansQ131452
P304page(s)7436-7443
P577publication date2016-10-10
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleAntibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions
P478volume60

Reverse relations

cites work (P2860)
Q52601747A Cell-Penetrating Peptide Fused Phage Lysin Kills Intracellular MRSA in Keratinocytes and Treatment for Skin Infections of Mice.
Q59356188Activity of the Chimeric Lysin ClyR against Common Gram-Positive Oral Microbes and Its Anticaries Efficacy in Rat Models
Q92377206Contributions of Net Charge on the PlyC Endolysin CHAP Domain
Q55002788Curcumin as a Promising Antibacterial Agent: Effects on Metabolism and Biofilm Formation in S. mutans.
Q59360278Effects of a Chimeric Lysin against Planktonic and Sessile Hint at Potential Application in Endodontic Therapy
Q52642775Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.
Q39369783Targeted antimicrobial therapy in the microbiome era.

Search more.